| 注册
首页|期刊导航|哈尔滨医药|哮喘和慢阻肺及哮喘-慢阻肺重叠综合征患者生物学标志物的比较分析

哮喘和慢阻肺及哮喘-慢阻肺重叠综合征患者生物学标志物的比较分析

姚智慧 刘兴东 谢君英

哈尔滨医药2026,Vol.46Issue(2):19-22,4.
✕
哈尔滨医药2026,Vol.46Issue(2):19-22,4.DOI:10.3969/j.issn.1001-8131.2026.02.005

哮喘和慢阻肺及哮喘-慢阻肺重叠综合征患者生物学标志物的比较分析

Comparison of Biomarkers in Asthma COPD and Asthma-COPD Overlap

姚智慧 1刘兴东 1谢君英1

作者信息

  • 1. 衡阳市第一人民医院,湖南 衡阳 421002
  • 折叠

摘要

Abstract

Objective To compare biomarkers in asthma,COPD,and asthma-COPD overlap(ACO).Methods 50 patients per group(asthma,COPD,ACO,and healthy controls)were included.Inflammatory,protease-related,and fibrotic biomarkers were analyzed.Correlation analysis assessed biomarker-disease associations.Results Eosinophilic markers(FeNO,IL-5)were highest in asthma,neutrophil/protease markers(MMP-9,NE)in COPD,and TGF-β in ACO.FeNO correlated strongly with asthma,MMP-9 with COPD,and TGF-β most strongly with ACO.Conclusion Asthma shows eosinophilic inflammation,COPD exhibits neutrophilic inflammation and oxidative stress,while ACO combines features of both with a distinct pro-fibrotic profile.

关键词

哮喘/慢性阻塞性肺疾病/哮喘-慢阻肺重叠综合征/生物标志物

Key words

Asthma/COPD/Asthma-COPD Overlap/Biomarkers

分类

医药卫生

引用本文复制引用

姚智慧,刘兴东,谢君英..哮喘和慢阻肺及哮喘-慢阻肺重叠综合征患者生物学标志物的比较分析[J].哈尔滨医药,2026,46(2):19-22,4.

基金项目

湘南学院附属衡阳医院专项项目(202411807) (202411807)

哈尔滨医药

1001-8131

访问量0
|
下载量0
段落导航相关论文